LeonaBio (LONA) EBIT Growth (1y) (2020 - 2026)
LeonaBio (LONA) EBIT Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | -80.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.52% |
| Dec 31, 2025 | -404.72% |
| Sep 30, 2025 | 76.79% |
| Jun 30, 2025 | 73.99% |
| Mar 31, 2025 | 65.56% |
| Dec 31, 2024 | 46.35% |
| Sep 30, 2024 | 15.47% |
| Jun 30, 2024 | 11.42% |
| Mar 31, 2024 | 7.00% |
| Dec 31, 2023 | 11.88% |
| Sep 30, 2023 | -45.20% |
| Jun 30, 2023 | -34.24% |
| Mar 31, 2023 | -27.29% |
| Dec 31, 2022 | -75.35% |
| Sep 30, 2022 | -35.38% |
| Jun 30, 2022 | -41.67% |
| Mar 31, 2022 | -116.93% |
| Dec 31, 2021 | -106.83% |
| Sep 30, 2021 | -140.99% |
| Jun 30, 2021 | -638.77% |